Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.
Carrión JA, Gonzalez-Colominas E, García-Retortillo M, Cañete N, Cirera I, Coll S, Giménez MD, Márquez C, Martin-Escudero V, Castellví P, Navinés R, Castaño JR, Galeras JA, Salas E, Bory F, Martín-Santos R, Solà R. Carrión JA, et al. Among authors: salas e. J Hepatol. 2013 Nov;59(5):926-33. doi: 10.1016/j.jhep.2013.06.019. Epub 2013 Jun 26. J Hepatol. 2013. PMID: 23811030 Clinical Trial.
Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence.
González-Colominas E, Broquetas T, Retamero A, García-Retortillo M, Cañete N, Coll S, Pellicer R, Giménez MD, Cabrero B, Bory F, Knobel H, Salas E, Solà R, Carrión JA. González-Colominas E, et al. Among authors: salas e. Liver Int. 2015 May;35(5):1557-65. doi: 10.1111/liv.12729. Epub 2014 Dec 15. Liver Int. 2015. PMID: 25385188
[Prevalence of potential interactions between antiretroviral therapy and boceprevir or telaprevir in human immunodeficiency virus-hepatitis C virus coinfected patients].
González-Colominas E, Solà R, Barrantes-González M, Salas E. González-Colominas E, et al. Among authors: salas e. Enferm Infecc Microbiol Clin. 2013 May;31(5):350-1. doi: 10.1016/j.eimc.2012.09.016. Epub 2012 Nov 23. Enferm Infecc Microbiol Clin. 2013. PMID: 23182365 Spanish. No abstract available.
Computerized pharmacy surveillance and alert system for drug-related problems.
Ferrández O, Urbina O, Grau S, Mateu-de-Antonio J, Marin-Casino M, Portabella J, Mojal S, Riu M, Salas E. Ferrández O, et al. Among authors: salas e. J Clin Pharm Ther. 2017 Apr;42(2):201-208. doi: 10.1111/jcpt.12495. Epub 2017 Jan 12. J Clin Pharm Ther. 2017. PMID: 28078665
Design of a score to identify hospitalized patients at risk of drug-related problems.
Urbina O, Ferrández O, Grau S, Luque S, Mojal S, Marin-Casino M, Mateu-de-Antonio J, Carmona A, Conde-Estévez D, Espona M, González E, Riu M, Salas E. Urbina O, et al. Among authors: salas e. Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):923-32. doi: 10.1002/pds.3634. Epub 2014 May 10. Pharmacoepidemiol Drug Saf. 2014. PMID: 24817497
508 results